Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

81.56

+1.71 (2.14%)

At close: Jun 24, 2026, 4:00 PM EDT

81.76

+0.20 (0.25%)

After-hours: Jun 24, 2026, 7:50 PM EDT

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	8,756	3,688	5,297	3,359	2,190	2,098
Market Cap Growth	17.00%	-30.38%	57.70%	53.35%	4.41%	-31.31%
Enterprise Value	8,250	3,322	4,920	2,991	1,760	1,875
Last Close Price	81.56	34.80	50.39	32.48	20.31	19.80
PE Ratio	202.88	42.44	40.97	34.55	23.34	22.25
Forward PE	70.36	55.53	32.11	32.61	19.95	21.01
PEG Ratio	-	-	-	-	-	1.50
PS Ratio	11.38	4.84	7.85	6.96	5.45	5.73
PB Ratio	13.72	5.69	7.79	6.63	4.36	5.58
P/TBV Ratio	14.84	6.45	8.41	7.16	4.69	6.64
P/FCF Ratio	72.87	26.01	27.01	26.54	18.26	12.53
P/OCF Ratio	72.69	25.97	26.71	26.51	18.20	12.49
EV/Sales Ratio	10.73	4.36	7.29	6.20	4.38	5.12
EV/EBITDA Ratio	-	72.29	35.72	27.61	15.45	14.88
EV/EBIT Ratio	-	74.15	35.93	27.88	15.62	15.06
EV/FCF Ratio	68.66	23.43	25.09	23.63	14.67	11.20
Debt / Equity Ratio	0.01	0.01	0.01	0	0	0
Debt / EBITDA Ratio	-	0.13	0.05	0.00	0.01	0.00
Debt / FCF Ratio	0.08	0.04	0.04	0.00	0.01	0.00
Net Debt / Equity Ratio	-0.51	-0.56	-0.55	-0.73	-0.86	-0.59
Net Debt / EBITDA Ratio	48.62	-7.97	-2.73	-3.40	-3.78	-1.77
Net Debt / FCF Ratio	-2.74	-2.58	-1.92	-2.91	-3.59	-1.33
Asset Turnover	0.93	0.91	0.92	0.80	0.80	0.74
Inventory Turnover	1.04	1.03	1.08	0.94	0.97	1.07
Quick Ratio	2.53	2.60	3.11	4.05	6.58	5.28
Current Ratio	2.86	2.92	3.35	4.39	6.89	5.60
Return on Equity (ROE)	7.36%	15.01%	23.81%	21.05%	23.11%	25.03%
Return on Assets (ROA)	-3.89%	8.01%	16.38%	15.17%	19.52%	22.51%
Return on Invested Capital (ROIC)	-8.64%	18.60%	44.95%	73.62%	80.87%	88.53%
Return on Capital Employed (ROCE)	-1.23%	6.54%	22.51%	20.87%	25.39%	27.65%
Earnings Yield	0.53%	2.36%	2.44%	2.89%	4.28%	4.49%
FCF Yield	1.37%	3.84%	3.70%	3.77%	5.48%	7.98%
Buyback Yield / Dilution	-0.16%	-5.73%	-1.56%	3.64%	7.94%	-1.42%
Total Shareholder Return	-0.16%	-5.73%	-1.56%	3.64%	7.94%	-1.42%

SEC Filings: 10-K · 10-Q